Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-02900-0002-0000-5 |
Chemical Name: | Theophylline |
CASRN: | 58-55-9 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 298713_CA |
Study Result: | Negative |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Negative |
Induced Rat Liver S9 | 1_S9 | Negative |
No Activation | 2 | Negative |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 5 | 0.050 | 4.0 | 0 | 0.000 | 0.0 | 4 | 0.040 | 3.0 | 1 | 0.010 | 1.0 |
Dimethyl Sulfoxide | 0 | 100 | 14 | 0.140 | 11.0 | 4 | 0.040 | 4.0 | 10 | 0.100 | 7.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Theophylline | 510 | 100 | 7 | 0.070 | 6.0 | 2 | 0.020 | 2.0 | 3 | 0.030 | 3.0 | 2 | 0.020 | 2.0 |
555 | 100 | 8 | 0.080 | 6.0 | 2 | 0.020 | 2.0 | 4 | 0.040 | 2.0 | 2 | 0.020 | 2.0 | ||
600 | 100 | 9 | 0.090 | 8.0 | 3 | 0.030 | 3.0 | 2 | 0.020 | 2.0 | 4 | 0.040 | 4.0 | ||
Positive Control: | Mitomycin-C | 0.025 | 100 | 22 | 0.220 | 16.0 | 12 | 0.120 | 10.0 | 10 | 0.100 | 9.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.063 | 25 | 25 | 1.000 | 36.0 | 10 | 0.400 | 24.0 | 5 | 0.200 | 20.0 | 10 | 0.400 | 1.0 | |
Trend: | -0.761 | -0.417 | -1.953 | ||||||||||||
Probability: | 0.777 | 0.662 | 0.975 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 2 | 0.020 | 2.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 |
Dimethyl Sulfoxide | 0 | 100 | 3 | 0.030 | 3.0 | 2 | 0.020 | 2.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Theophylline | 510 | 100 | 2 | 0.020 | 2.0 | 1 | 0.010 | 1.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
555 | 100 | 2 | 0.020 | 2.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 1 | 0.010 | 1.0 | ||
600 | 100 | 5 | 0.050 | 4.0 | 2 | 0.020 | 2.0 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 7.5 | 100 | 22 | 0.220 | 17.0 | 4 | 0.040 | 4.0 | 15 | 0.150 | 13.0 | 3 | 0.030 | 3.0 |
Cyclophosphamide | 37.5 | 50 | 26 | 0.520 | 32.0 | 13 | 0.260 | 20.0 | 13 | 0.260 | 20.0 | 0 | 0.000 | 0.0 | |
Trend: | 0.400 | -0.007 | 0.982 | ||||||||||||
Probability: | 0.345 | 0.503 | 0.163 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 3 | 0.030 | 3.0 | 2 | 0.020 | 2.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
Dimethyl Sulfoxide | 0 | 100 | 8 | 0.080 | 5.0 | 1 | 0.010 | 1.0 | 6 | 0.060 | 3.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Theophylline | 510 | 100 | 4 | 0.040 | 4.0 | 2 | 0.020 | 2.0 | 1 | 0.010 | 1.0 | 1 | 0.010 | 1.0 |
555 | 100 | 4 | 0.040 | 3.0 | 2 | 0.020 | 2.0 | 1 | 0.010 | 1.0 | 1 | 0.010 | 1.0 | ||
600 | 100 | 2 | 0.020 | 2.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 1 | 0.010 | 1.0 | ||
Positive Control: | Mitomycin-C | 0.025 | 100 | 12 | 0.120 | 7.0 | 5 | 0.050 | 4.0 | 7 | 0.070 | 5.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.063 | 50 | 24 | 0.480 | 36.0 | 11 | 0.220 | 22.0 | 12 | 0.240 | 22.0 | 1 | 0.020 | 1.0 | |
Trend: | -1.217 | 0.007 | -1.808 | ||||||||||||
Probability: | 0.888 | 0.497 | 0.965 |